The significance of transarterial chemo(embolization) combined with tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma in the era of systemic therapy: a systematic review

HIGHLIGHTS

• who: Qiao Ke from the melweis University, Hungary Technology, China have published the research: The Significance of Transarterial Chemo(Embolization) Combined With Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review, in the Journal: (JOURNAL)
• what: For uHCC patients at intermediate stage according to the Barcelona Clinic Liver Cancer stage (BCLC) , transarterial chemoembolization (TACE), as a classical modality of transarterial chemo(embolization), is strongly recommended with the overall objective response rate (ORR) beyond 50% . Frontiers in Immunology | www.frontiersin.org MATERIAL AND METHOD This . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.